VEGFA and cancer: Anti-angiogenic therapy for targeting the tumor vasculature has been recently used in various cancer patients, as the function of vascular endothelial growth factor (VEGF)-family ligands and their receptors is critical in tumor angiogenesis1, 2, 3.